Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Filhine-Tresarrieu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
JMIR Formative Research|January 28, 2026
Development and Validation of a Protein Electrophoresis Classification Algorithm: Tabular Data-Based AlternativeAuriane Mazuir, Gatien Ricotier, Pierre Filhine-Tresarrieu
Expert Review of Molecular Diagnostics|January 17, 2019
Technical considerations for circulating tumor DNA detection in oncologyClaire Franczak, Pierre Filhine-Tresarrieu, Pauline Gilson, et al.
Oncology Letters|December 1, 2016
Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targetsShuhui Chen, Elisa Cavazza, Catherine Barlier, et al.
Targeted Oncology|December 15, 2015
Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation SequencingAlexandre Harlé, Pierre Filhine-Tresarrieu, Marie Husson, et al.
Medicine|November 12, 2015
Diagnostic Accuracy of Procalcitonin for Predicting Blood Culture Results in Patients With Suspected Bloodstream Infection: An Observational Study of 35,343 Consecutive Patients (A STROBE-Compliant Article)Abderrahim Oussalah, Janina Ferrand, Pierre Filhine-Tresarrieu, et al.
Journal of Clinical Medicine|April 26, 2019
Global Burden Related to Nitrous Oxide Exposure in Medical and Recreational Settings: A Systematic Review and Individual Patient Data Meta-AnalysisAbderrahim Oussalah, Mélissa Julien, Julien Levy, et al.
European Journal of Clinical Investigation|March 7, 2025
Mid-regional pro-adrenomedullin: A rapid sepsis biomarker for diagnosing spontaneous bacterial peritonitis in cirrhosisAbderrahim Oussalah, Vincent Haghnejad, Maël Silva Rodriguez, et al.
Ebiomedicine|April 9, 2018
Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular CarcinomaAbderrahim Oussalah, Susann Rischer, Mouni Bensenane, et al.
Nature Communications|February 4, 2018
Publisher Correction: A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patientsJean-Louis Guéant, Céline Chéry, Abderrahim Oussalah, et al.
Nature Communications|January 6, 2018
APRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patientsJean-Louis Guéant, Céline Chéry, Abderrahim Oussalah, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
JMIR Formative Research|January 28, 2026
Development and Validation of a Protein Electrophoresis Classification Algorithm: Tabular Data-Based AlternativeAuriane Mazuir, Gatien Ricotier, Pierre Filhine-Tresarrieu
Expert Review of Molecular Diagnostics|January 17, 2019
Technical considerations for circulating tumor DNA detection in oncologyClaire Franczak, Pierre Filhine-Tresarrieu, Pauline Gilson, et al.
Oncology Letters|December 1, 2016
Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targetsShuhui Chen, Elisa Cavazza, Catherine Barlier, et al.
Targeted Oncology|December 15, 2015
Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation SequencingAlexandre Harlé, Pierre Filhine-Tresarrieu, Marie Husson, et al.
Medicine|November 12, 2015
Diagnostic Accuracy of Procalcitonin for Predicting Blood Culture Results in Patients With Suspected Bloodstream Infection: An Observational Study of 35,343 Consecutive Patients (A STROBE-Compliant Article)Abderrahim Oussalah, Janina Ferrand, Pierre Filhine-Tresarrieu, et al.
Journal of Clinical Medicine|April 26, 2019
Global Burden Related to Nitrous Oxide Exposure in Medical and Recreational Settings: A Systematic Review and Individual Patient Data Meta-AnalysisAbderrahim Oussalah, Mélissa Julien, Julien Levy, et al.
European Journal of Clinical Investigation|March 7, 2025
Mid-regional pro-adrenomedullin: A rapid sepsis biomarker for diagnosing spontaneous bacterial peritonitis in cirrhosisAbderrahim Oussalah, Vincent Haghnejad, Maël Silva Rodriguez, et al.
Ebiomedicine|April 9, 2018
Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular CarcinomaAbderrahim Oussalah, Susann Rischer, Mouni Bensenane, et al.
Nature Communications|February 4, 2018
Publisher Correction: A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patientsJean-Louis Guéant, Céline Chéry, Abderrahim Oussalah, et al.
Nature Communications|January 6, 2018
APRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patientsJean-Louis Guéant, Céline Chéry, Abderrahim Oussalah, et al.
Pageof 1